The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.

AIMS Release from prison is a high-risk period for mortality. We examined the impact of opioid substitution therapy (OST), for opioid dependence during and after incarceration, upon mortality post-release. DESIGN A cohort was formed of all opioid-dependent people who entered OST between 1985 and 2010 and who, following first OST entry, were released from prison at least once between 2000 and 2012. We linked data on OST history, court and prison records and deaths. SETTING New South Wales (NSW), Australia. PARTICIPANTS A total of 16,453 people released from prison 60,161 times. MEASUREMENTS Crude mortality rates (CMRs) were calculated according to OST retention; multivariable Cox regressions for post-release periods were undertaken to examine the association between OST exposure (a time-dependent variable) and mortality post-release, for which covariates were updated per-release. FINDINGS There were 100,978 person-years (PY) post-release; 1050 deaths occurred. Most received OST while incarcerated (76.5%); individuals were receiving OST in 51% of releases. Lowest post-release mortality was among those continuously retained in OST post-release CMR 4 weeks post-release = 6.4 per 1000 PY; 95% confidence interval (CI) = 5.2, 7.8, highest among those with no OST (CMR = 36.7 per 1000 PY; 95% CI = 28.8, 45.9). Multi-factorial models showed OST exposure in the 4 weeks post-release reduced hazard of death by 75% (adjusted hazard ratio 0.25; 95% CI = 0.12, 0.53); OST receipt in prison had a short-term protective effect that decayed quickly across time. CONCLUSION In New South Wales, Australia, opioid substitution therapy in prison and post-release appears to reduce mortality risk in the immediate post-release period.

[1]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[2]  T. Vos,et al.  The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. , 2014, Addiction.

[3]  Greg Freedman,et al.  Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[4]  P. Vickerman,et al.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[5]  J. Steiner,et al.  Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.

[6]  M. Farrell,et al.  Opioid maintenance in European prisons: is the treatment gap closing? , 2012, Addiction.

[7]  L. Møller,et al.  The effectiveness of opioid maintenance treatment in prison settings: a systematic review. , 2012, Addiction.

[8]  Barbara Toson,et al.  Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. , 2012, Addiction.

[9]  J. Rich,et al.  Corrigendum to “Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey” [Drug Alcohol Depend., 105(1–2) 2009 83–88] , 2011 .

[10]  L. Degenhardt,et al.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.

[11]  M. Farrell,et al.  Meta-analysis of drug-related deaths soon after release from prison , 2010, Addiction.

[12]  S. Larney.  Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. , 2010, Addiction.

[13]  J. Rich,et al.  Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. , 2018, Journal of opioid management.

[14]  J. Rich,et al.  Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. , 2009, Drug and alcohol dependence.

[15]  W. Hall,et al.  Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. , 2009, Drug and alcohol dependence.

[16]  Louisa Degenhardt,et al.  Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. , 2009, Addiction.

[17]  K. Dolan,et al.  A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care? , 2009, European Addiction Research.

[18]  A. Verster,et al.  Interventions to reduce HIV transmission related to injecting drug use in prison. , 2009, The Lancet. Infectious diseases.

[19]  Jason M. White,et al.  Exposure to opioid maintenance treatment reduces long-term mortality. , 2008, Addiction.

[20]  M. Farrell,et al.  Acute risk of drug-related death among newly released prisoners in England and Wales. , 2008, Addiction.

[21]  K. O’grady,et al.  A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release. , 2007, Drug and alcohol dependence.

[22]  Anke Stallwitz,et al.  The impact of substitution treatment in prisons--a literature review. , 2007, The International journal on drug policy.

[23]  J. Kaldor,et al.  Suicide risk among recently released prisoners in New South Wales, Australia , 2007, The Medical journal of Australia.

[24]  J. Elmore,et al.  Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.

[25]  S. Darke.  Mortality amongst illicit drug users , 2006 .

[26]  Eileen Baldry,et al.  Ex-Prisoners, Homelessness and the State in Australia , 2006 .

[27]  Queensland,et al.  Australian and New Zealand Standard Offence Classification , 2006 .

[28]  Jacqueline Fitzgerald,et al.  Matching Court Records to Measure Reoffending , 2006 .

[29]  E. Hammerby,et al.  Mortality among Danish drug users released from prison , 2006 .

[30]  J. Kaldor,et al.  Mortality among prisoners: how accurate is the Australian National Death Index? , 2005, Australian and New Zealand journal of public health.

[31]  M. Brugal,et al.  Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. , 2005, Addiction.

[32]  R. Mattick,et al.  The Effectiveness Of Methadone Maintenance Treatment In Controlling Crime An Australian Aggregate-Level Analysis , 2004 .

[33]  A. Tonkin,et al.  Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study , 2003, Australian and New Zealand journal of public health.

[34]  G. Patton,et al.  Mortality in young offenders: retrospective cohort study , 2003, BMJ : British Medical Journal.

[35]  S. Bird,et al.  Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. , 2003, Addiction.

[36]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[37]  L. Degenhardt,et al.  Opioid overdose mortality in Australia, 1964–1997: birth‐cohort trends , 1999, The Medical journal of Australia.

[38]  O. Drummer,et al.  Mortality associated with New South Wales methadone programs in 1994: lives lost and saved , 1999 .

[39]  R. Brettle,et al.  Mortality from overdose among injecting drug users recently released from prison: database linkage study , 1998, BMJ.

[40]  Jeff Hall.  Methadone Maintenance Treatment and other Opioid Replacement Therapies , 1997 .

[41]  F. Forastiere,et al.  Longitudinal and cross sectional mortality studies in injecting drug-users. , 1994, Journal of Epidemiology and Community Health.

[42]  D. Harding-Pink.  Mortality following Release from Prison , 1990, Medicine, science, and the law.